SCHEMBL8422338

SCHEMBL8422338

CCOC(=O)c1c(-c2ccccc2)nn(-c2ccccc2)c1-c1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.68
CYP2C9 P11712 3/20 0.68
CYP2C19 P33261 3/20 0.68
CYP3A4 P08684 2/20 0.68
CA1 P00915 1/20 0.61
CA2 P00918 1/20 0.61
PDE4D Q08499 1/20 0.60
NPSR1 Q6W5P4 4/20 0.58
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
CYP1A2 P05177 1/20 0.57
TSHR P16473 4/20 0.54
ADORA3 P0DMS8 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
HTT P42858 1/20 0.53
HSD17B10 Q99714 1/20 0.53
LMNA P02545 1/20 0.53
MAPT P10636 2/20 0.52
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15153244 0.93 ALDH1A1 (0.67) ALDH1A1CYP2C9CYP2C19CYP3A4CA1
SCHEMBL6264973 0.88 PDE4D (0.73) ALDH1A1CYP2C9CYP2C19CYP3A4PDE4D
SCHEMBL12266478 0.88 PDE4D (0.73) ALDH1A1CYP2C9CYP2C19CYP3A4CA1
SCHEMBL12264387 0.86 ALDH1A1 (0.67) ALDH1A1CYP2C9CYP2C19CYP3A4CA1
SCHEMBL14133072 0.86 MEN1 (0.64) ALDH1A1CYP2C9CYP2C19CYP3A4CA1
SCHEMBL650664 0.85 PDE4D (0.57) ALDH1A1CYP2C9CYP2C19CYP3A4PDE4D
SCHEMBL3390032 0.85 ALDH1A1 (0.65) ALDH1A1CYP2C9CYP2C19CYP3A4CA1
SCHEMBL28747558 0.81 ADORA3 (0.57) ALDH1A1CYP2C9CYP2C19CYP3A4CA1
SCHEMBL2919412 0.80 ALDH1A1 (0.73) ALDH1A1CYP2C9CYP2C19CYP3A4CA1
SCHEMBL4494401 0.80 CYP2C9 (0.69) ALDH1A1CYP2C9CYP2C19CYP3A4CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2552895-B1 PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES Westfälische Wilhelms Universität Münster (DE) 2015-02-25 EP disclosed
US-8716485-B2 Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines WESTFÄLISHE WILHELMS-UNIVERSITÄT MÜNSTER (DE) 2014-05-06 US disclosed
US-8716485-B2 Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines WESTFÄLISHE WILHELMS-UNIVERSITÄT MÜNSTER (DE) 2014-05-06 US disclosed
US-8716485-B2 Pyrazole synthesis by coupling of carboxylic acid derivatives and enamines WESTFÄLISHE WILHELMS-UNIVERSITÄT MÜNSTER (DE) 2014-05-06 US disclosed
US-20130012715-A1 PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES WESTFAELISCHE WILHELMS UNIVERSITAET MUENSTER (DE) 2013-01-10 US disclosed
US-20130012715-A1 PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES WESTFAELISCHE WILHELMS UNIVERSITAET MUENSTER (DE) 2013-01-10 US disclosed
US-20130012715-A1 PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES WESTFAELISCHE WILHELMS UNIVERSITAET MUENSTER (DE) 2013-01-10 US disclosed
US-20120302581-A1 Methods and Compositions for the Treatment of RAS Associated Disorders THE TRUSTEES OF DARTMOUTH COLLEGE 2012-11-29 US disclosed
US-20120302581-A1 Methods and Compositions for the Treatment of RAS Associated Disorders THE TRUSTEES OF DARTMOUTH COLLEGE 2012-11-29 US disclosed
WO-2011120861-A1 PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES WESTFÄLISHE WILHELMS-UNIVERSITÄT MÜNSTER (DE) 2011-10-06 WO disclosed
US-5908852-A 1,3,5 trisubstituted pyrazole compounds for treatment of inflammation G. D. SEARLE & CO. (US) 1999-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130012715-A1 PYRAZOLE SYNTHESIS BY COUPLING OF CARBOXYLIC ACID DERIVATIVES AND ENAMINES PC, ENO1, PDK2 ALDH1A1 361/4885CYP2C9 62/4885CYP2C19 81/4885
US-20120302581-A1 Methods and Compositions for the Treatment of RAS Associated Disorders NRAS, HRAS, KRAS ALDH1A1 3966/4885CYP2C9 4875/4885CYP2C19 4827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.